CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 59 enrolled
Drug / intervention
Usual Care +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03030859
NCT03030859N/ACompleted
CompareCT.gov

Self-Care for Head and Neck Cancer Survivors With Lymphedema and Fibrosis

University of Pennsylvania·interventional·Posted Jan 25, 2017·Updated Apr 11, 2024

In Brief

A clinical study evaluating Usual Care, Usual Care plus LEF-SCP, and 1 other intervention for Head and Neck Cancer and 2 related conditions. Completed, enrolled 59 participants across 1 site.

Detailed Summary

This randomized pilot clinical trial studies how well the self-care program works in head and neck cancer survivors with lymphedema and fibrosis. A self-care program may promote self-care activities for managing chronic swelling and tough/tight tissues in the head and neck region.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead and Neck Cancer, Lymphedema, Fibrosis
CountriesUnited States
CollaboratorsAmerican Cancer Society, Inc., National Cancer Institute (NCI)

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 25, 2017
Enrollment StartJun 1, 2018
Primary CompletionMar 31, 2022
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 9.4 years ago

Interventions

Usual Careother

Undergo usual care only

Usual Care plus LEF-SCPother

Undergo Motivational Interviewing sessions and LEF Self-Care Training sessions, as well as review LEF self-care educational manual and videos

Usual Care plus LEF-SCP plus Follow-upother

Undergo Motivational Interviewing sessions and LEF Self-Care Training sessions, and review LEF self-care educational manual and videos, as well as meet with the study lymphedema therapist